Search

Search Constraints

You searched for: Author/Creator Michaelis, Laura C.

Search Results

1. A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Issue 2 (28th January 2023)

3. Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. Issue 1 (2nd January 2021)

4. Early mortality in patients with acute myelogenous leukemia treated in teaching versus non‐teaching hospitals: A large database analysis. Issue 9 (7th July 2017)

5. Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Issue 1 (2nd January 2023)

6. Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia. Issue 2 (4th December 2017)